Aude Le Breton
Immunology · 2012
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 8 citations into it
Whom Aude Le Breton trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- D. Cheresh (in Immunology and Allergy)
Papers from Aude Le Breton's perspective
Ordered by how strongly the researchers Aude Le Breton trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular mechanisms and clinical applications of angiogenesis (Nature)
- Integrins in cancer: biological implications and therapeutic opportunities (Nature Reviews. Cancer)
- Pattern recognition receptors and inflammation. (Cell)
- Pathogen recognition in the innate immune response. (Biochemical Journal)
- Therapeutic Nanoparticles for Drug Delivery in Cancer (Clinical Cancer Research)
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles (Molecular Pharmaceutics)
- Nanoparticles target distinct dendritic cell populations according to their size (European Journal of Immunology)
- Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) (Nature Biotechnology)
- Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. (International journal of pharmaceutics)
- Biodegradable nanoparticles for drug and gene delivery to cells and tissue. (Advanced Drug Delivery Reviews)
Their papers
- PLGA-based nanoparticles: an overview of biomedical applications. (2012) — 3,515 citations
- RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. (2012) — 898 citations